DESTINY-PANTUMOUR04

Trial Identifier: D781WR00001
Sponsor: AstraZeneca
Start Date: September 2025
Primary Completion Date: March 2028
Study Completion Date: March 2028
Condition: Cancer - Other; Endometriosis; Esophageal cancer; Head and Neck Cancer; Liver Cancer; Skin Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Lung Cancer; Testicular Cancer; Thyroid Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
USA, Alabama Birmingham, Alabama, USA, 35223
USA, Arizona Casa Grande, Arizona, USA, 85122
USA, Florida Coral Springs, Florida, USA, 33065
USA, Florida Fort Myers, Florida, USA, 33901
USA, Illinois O'Fallon, Illinois, USA, 62269
USA, North Carolina Wilson, North Carolina, USA, 27893
USA, Ohio Canton, Ohio, USA, 44718
USA, Ohio Maumee, Ohio, USA, 43537